MedTrace Logo

Cytokines Supplementation to Culture Media and ICSI Outcome

NCT04547699 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 700

Last updated 2023-06-18

No results posted yet for this study

Summary

A randomized clinical trial to evaluate the effect of cytokine supplementation in embryo culture medium with various protein concentrations aiming to evaluate the effects of cytokines (CYK) integration into the human in vitro culture medium with high and low human serum albumin (HSA) concentrations on live birth rates after intracytoplasmic sperm injection (ICSI).

Conditions

  • ICSI

Interventions

COMBINATION_PRODUCT

A single step culture medium

A single step culture medium (SSCM; Global, Life Global)+5mg/ml life global protein, without supplementation of CYK

Sponsors & Collaborators

  • Rahem Fertility Center

    collaborator OTHER

  • Mansoura Integrated Fertility Center

    lead OTHER

Principal Investigators

  • Emad M Sedeek, MS · MIFC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
38 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-01
Primary Completion
2021-07-01
Completion
2022-07-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04547699 on ClinicalTrials.gov